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Gastric carcinoma MKN45 cells stably transfected with the full-
length ST3GAL4 gene were characterised by glycomic and sialo-
proteomic analysis. Complementary strategies were applied to
assess the glycomic alterations induced by ST3GAL4 over-
expression. The N- and O-glycome data were generated in two
parallel structural analyzes, based on PGC-ESI-MS/MS. Data on
glycan structure identiﬁcation and relative abundance in
ST3GAL4 overexpressing cells and respective mock control are
presented. The sialoproteomic analysis based on titanium-
dioxide enrichment of sialopeptides with subsequent LC-MS/MS
identiﬁcation was performed. This analysis identiﬁed 47 proteins
with signiﬁcantly increased sialylation. The data in this article is
associated with the research article published in Biochim Biophys
Acta “Glycomic analysis of gastric carcinoma cells disclosesvier Inc. This is an open access article under the CC BY license
/j.bbagen.2015.12.016
estigação e Inovação em Saúde, University of Porto, Portugal.
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S. Mereiter et al. / Data in Brief 7 (2016) 814–833 815glycans as modulators of RON receptor tyrosine kinase activation
in cancer” [1].
& 2016 The Authors. Published by Elsevier Inc. This is an open
access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Speciﬁcations Tableubject area Biology
ore speciﬁc sub-
ject areaGlycobiology in cancerype of data Tables
ow data was
acquiredN-and O-glycome analysed by PGC-LC ESI MS/MS performed on an LTQ ion trap
mass spectrometer and PGC-nanoLC ESI MS/MS performed on an amaZon ETD
Speed ion trap. Sialoproteome performed using Easy-nLC II system and Orbitrap
Fusion Tribrid system.ata format Analyzed
xperimental
factorsMKN45 cells stably transfected with the full-length ST3GAL4 gene or empty
vector (mock).xperimental
featuresMKN45 cells grown in vitro in RPMI medium with 10% FBS.ata source
locationNot applicableata accessibility Data is within this article.Value of the data
 Data shows the N- and O-glycome of the MKN45 gastric carcinoma cells and ST3GAL4 sialyl-
transferase overexpressing cells.
 Data provides a list of glycoproteins with altered sialylated N-glycans in ST3GAL4 overexpressing
cells, including several cancer associated proteins.
 These data are valuable as a source for novel biomarkers for gastric cancer.1. Data
This data article includes the N- and O-glycome of MKN45 cells and assesses the glycosylation
alterations induced by ST3GAL4 overexpression. In addition, we provide the data on the proteins with
signiﬁcant increased sialylated N-glycans upon ST3GAL4 overexpression.2. Experimental design, materials and methods
Glycomic and sialoproteomic analyses were performed as described below comparing MKN45
cells stably transfected with the full-length ST3GAL4 gene or empty vector (mock). Glycome data and
statistical evaluation are shown in Tables 1, 2, 3 and 4. Sialoproteome data and statistical evaluation
are shown in Tables 5 and 6.
S. Mereiter et al. / Data in Brief 7 (2016) 814–8338163. N-glycomic strategy I: sample preparation and PGC LC-ESI-MS/MS
Frozen cell pellets (107 cells) of mock or ST3GAL4 transfected MKN45 cells [2] were directly
resuspended in 7 M urea, 2 M thiourea, 40 mM Tris, 2% CHAPS, 10 mM DTT and 1% protease inhibitor
(Sigma-Aldrich, St. Louis, MO). The cell membranes were disrupted by 10 times 10 s sonication with
16 amplitudes and 1 min on ice in between, and subsequent shaking at 4 °C overnight. To reduce the
viscosity of the lysates, the DNAwas degraded by adding 1 ml benzonases nuclease (250 units, Sigma-
Aldrich) and 30 min incubation at 37 °C. In order to impair refolding of proteins, 25 mM iodoaceta-
mide were added for alkylation during 1 h in the dark. The lysates were centrifuged for 30 min at
14,000 rpm and the supernatants were transferred to a fresh tube.
Then, solubilized proteins were concentrated by adding 150 ml of supernatant on a 10 kDa cut-off
spinﬁlter (PALL, Port Washington, NY), spinning down for 5 min with 12,000xg and washing 3 times
with 100 ml 50 mM NH4HCO3, pH 8.4. N-linked oligosaccharides were released in the spinﬁlter using
20 ml 50 mM NH4HCO3 and PNGase F (5 mU, Prozyme, Hayward, CA) with incubation at 37 °C over-
night. Subsequently, the N-glycans were collected by washing 3 times with 20 ml H2O and dried in
Speedvac. Reactions were quenched with 1 ml of glacial acetic acid and N-glycan samples were
desalted and dried as previously described [3]. N-glycan samples were subjected to LC-ESI-MS/MS
analysis using a 10 cmx250 mm I.D. column, prepared in-house, containing 5 mm porous graphitized
carbon (PGC) particles (Thermo Scientiﬁc, Waltham, MA). Glycans were eluted using a linear gradient
from 0% to 40% acetonitrile in 10 mM NH4HCO3 over 40 min at a ﬂow rate of 10 μl/min. The eluted N-
glycans were detected using a LTQ ion trap mass spectrometer (Thermo Scientiﬁc) in negative-ion
mode with an electrospray voltage of 3.5 kV, capillary voltage of 33.0 V and capillary temperature of
300 °C. Air was used as a sheath gas and mass ranges were deﬁned dependent on the speciﬁc
structure to be analyzed. The data were processed using the Xcalibur software (version 2.0.7, Thermo
Scientiﬁc) and manually interpreted from their MS/MS spectra.
Optionally prior to analysis N-glycan were digested in 50 mM sodium phosphate, pH 6.0 at 37 °C
overnight using sialidase S (4 mU, ProZyme) that releases α2-3 linked non-reducing terminal sialic acidsTable 1
Identiﬁed N-glycan structures I.
Table 1 (continued )
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Table 1 (continued )
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Table 1 (continued )
Structures are represented by the mass to charge ratio (m/z) in which they were identiﬁed and quantiﬁed, by monosaccharide
composition and proposed structure based on MS/MS analyses. The relative quantities were determined by base-peak intensity
of extracted ion chromatograms. The average value (Avg) and standard deviation (SD) of triplicates are shown, as well as the p-
value (t-test; *po0.05; **po0.01; ***po0.001). Increased or decreased relative abundance are shown in red or blue,
respectively. Structures marked as not analyzed (na) were either not detected or overlapped with other structures in given
sample, precluding their quantiﬁcation. Unknown linkage is represented by “?”.
S. Mereiter et al. / Data in Brief 7 (2016) 814–833 819(recombinant sialidase from Streptococcus pneumoniae, expressed in Escherichia coli) and sialidase A
(5 mU, ProZyme) that releases α2-3/6/8 linked non-reducing terminal sialic acid (recombinant gene
from Arthrobacter ureafaciens, expressed in Escherichia coli) to conﬁrm sialic acid linkage.
All analyzes were performed in three independent replicates and results were subjected to sta-
tistical analyses (Average, standard deviation and unpaired t-test) Table 1.4. N-glycomic strategy II: sample preparation and PGC nanoLC-ESI MS/MS
Frozen cell pellets (107 cells) of mock or ST3GAL4 transfected MKN45 cells were directly resus-
pended in 2 mL of lysis buffer (50 mM Tris–HCl, 100 mM NaCl, 1 mM EDTA and protease inhibitor at
pH 7.4) and stored on ice for 20 min. The cells were lysed using a Polytron homogenizer for at least
three times for 10 s in a cold room. Cellular debris and unlysed cells were sedimented by cen-
trifugation at 2000g for 20 min at 4 °C. The supernatant was collected and the pellets resuspended in
1 mL of lysis buffer and centrifuged again at 2000g for 20 min at 4 °C. All the supernatants were
combined, diluted in 20 mM Tris–HCl (pH 7.4) and ultracentrifuged at 120,000g for 90 min at 4 °C.
The supernatant was separated from the pellet containing the cell membrane proteins. The mem-
brane proteins were resuspended with 150 μL of 100 mM ammonium bicarbonate buffer and lyo-
philized overnight. The dried samples were solubilized in 50 μL of 8 M urea and 10 mL aliquots were
dot-blotted onto PVDF membranes as described previously [4]. N- and O-glycan release as well as
Table 2
Identiﬁed N-glycan structures II.
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Table 2 (continued )
Structures are represented by their [M–H] value and charge state in which they were identiﬁed and quantiﬁed, by mono-
saccharide composition and proposed structure based on MS/MS analyzes. The relative quantities were determined by base-
peak intensity of extracted ion chromatograms. The ratio of glycan abundance in ST3GAL4 transfected cells relative to mock
transfected is shown on the right column. Increases or decreases larger than 2 fold in glycan abundance are highlighted red or
blue, respectively.
S. Mereiter et al. / Data in Brief 7 (2016) 814–833824
S. Mereiter et al. / Data in Brief 7 (2016) 814–833 825PGC-nanoLC ESI MS/MS analysis on an amaZon ETD Speed ion trap (Bruker, Bremen, Germany) were
performed as described in detail previously [4,5] (Table 2).5. O-glycomic strategy I: sample preparation and LC-ESI-MS/MS
After the removal of N-glycan, as previously described in “1. N-glycomic strategy I: Sample pre-
paration and LC-ESI-MS/MS”, the O-linked glycans were released from retained glycoproteins in
spinﬁlter using reductive β-elimination (0.5 M NaBH4, 50 mM NaOH at 50 °C, 16 h). Reactions were
quenched with 1 ml of glacial acetic acid and glycan samples were desalted and dried as previously
described [3]. Glycans were subjected to LC-ESI-MS/MS analysis using a 10 cmx250 mm I.D. column,
prepared in-house, containing 5 mm porous graphitized carbon (PGC) particles (Thermo Scientiﬁc.
Waltham. MA). Glycans were eluted using a linear gradient from 0% to 40% acetonitrile in 10 mM
NH4HCO3 over 40 min at a ﬂow rate of 10 μl/min. The eluted O-glycans were detected using a LTQ ion
trap mass spectrometer (Thermo Scientiﬁc) in negative-ion mode with an electrospray voltage of
3.5 kV, capillary voltage of 33.0 V and capillary temperature of 300 °C. Air was used as a sheath gas
and mass ranges were deﬁned dependent on the speciﬁc structure to be analyzed. The data were
processed using the Xcalibur software (version 2.0.7. Thermo Scientiﬁc) and manually interpreted
from their MS/MS spectra (Table 3).6. O-glycomic strategy II: sample preparation and PGC nanoLC-ESI MS/MS
Sample preparation and analysis were performed as previously described in Section 2. “N-gly-
comic strategy II: Sample preparation and PGC nanoLC-ESI MS/MS” (Table 4).7. Sialoproteomic analysis
7.1. Cell lysis, protein digestion and iTRAQ labeling
Cell pellets were redissolved in ice-cold Na2CO3 buffer (0.1 M, pH 11) supplemented with protease
inhibitor (Roche complete EDTA free), PhosSTOP phosphatase inhibitor cocktail (Roche) and 10 mM
sodium pervanadate on ice. The suspensions were tip probe sonicated for 20 s (amplitude¼50%)
twice and incubated at 4 °C for 1 h. The lysates were then centrifuged at 100,000 g for 90 min at
4 °C to enrich membrane proteins (pellet). The pellets were washed with 50 mM triethylammoniumTable 3
Identiﬁed O-glycan structures I.
Table 3 (continued )
Structures are represented by the mass to charge ratio (m/z) in which they were identiﬁed and quantiﬁed, by monosaccharide
composition and proposed structure based on MS/MS analyzes. The relative quantities were determined by base-peak intensity
of extracted ion chromatograms. The average value (Avg) and standard deviation (SD) of triplicates are shown, as well as the p-
value (t-test; *po0.05; **po0.01). Increased or decreased relative abundance are shown in red or blue, respectively. Unknown
linkage is represented by “?”.
S. Mereiter et al. / Data in Brief 7 (2016) 814–833826bicarbonate (TEAB) to remove any remaining soluble protein. Membrane fraction was resuspended
directly in 6 M urea and 2 M thiourea, reduced in 10 mM DTT for 30 min and then alkylated in 20 mM
IAA for 30 min at room temperature in the dark.
Samples were incubated with endoproteinase Lys-C (Wako, Osaka, Japan) for 2 h (1:100 w/w).
Following the incubation, the samples were diluted 8 times with 50 mM TEAB (pH 8) and trypsin was
added at a ratio of 1:50 (w/w) and left overnight at room temperature. Trypsin digestionwas stopped by
the addition of 2% formic acid and then the samples were centrifuged at 14,000 g for 10 min to
S. Mereiter et al. / Data in Brief 7 (2016) 814–833 827precipitate any lipids present in the sample. The supernatant was puriﬁed using in-house packed staged
tips with a mixture of Poros R2 and Oligo R3 reversed phase resins (Applied Biosystem, Foster City, CA,
USA). Brieﬂy, a small plug of C18 material (3 M Empore) was inserted in the end of a P200 tips, followed
by packing of the stage tip with the resins (resuspended in 100% ACN) by applying gentle air pressure.
The acidiﬁed samples were loaded onto the micro-column after equilibration of the column with 0.1%
triﬂuoroacetic acid (TFA), washed twice with 0.1% TFA and peptides were eluted with 60% ACN/0.1% TFA.
A small amount of puriﬁed peptides (1 μl) from each sample was subjected to Qubit assay to determine
the concentration, while the remaining samples were dried by vacuum centrifugation. Afterwards,
peptides were redissolved in dissolution buffer and a total of 150 μg for each condition was labeled with
4-plex iTRAQTM (Applied Biosystems, Foster City, CA) as described by the manufacturer. After labeling,
the samples were mixed 1:1:1:1 and lyophilized by vacuum centrifugation.
7.2. Sialic acid containing glycopeptide enrichment by TiSH protocol
The method used for sialylated glycopeptides enrichment is a modiﬁcation of the TiSH protocol [6]
described in [7,8]. Brieﬂy, samples were resuspended in loading buffer (1 M glycolic acid, 80% ACN, 5%Table 4
Identiﬁed O-glycan structures II.
Table 4 (continued )
Structures are represented by their [M–H] value and charge state in which they were identiﬁed and quantiﬁed, by mono-
saccharide composition, type of core and proposed structure based on MS/MS analyzes. The relative quantities were deter-
mined by base-peak intensity of extracted ion chromatograms. The ratio of glycan abundance in ST3GAL4 transfected cells
relative to mock transfected is shown on the right column. Increases or decreases greater than 1.5 fold in glycan abundance are
highlighted red or blue, respectively.
S. Mereiter et al. / Data in Brief 7 (2016) 814–833828TFA) and incubated with TiO2 beads (GL Sciences, Japan, 10 μm; using a total of 0.6 mg TiO2 beads per
100 μg of peptides). The supernatant containing the un-modiﬁed peptides was carefully separated.
The TiO2 beads were sequentially washed with loading buffer, washing buffer 1 (80% ACN, 1% TFA)
and washing buffer 2 (20% ACN, 0.1% TFA), saving the washings with the previous supernatant. The
bound peptides were eluted with 1.5% ammonium hydroxide by shaking for 15 min. The eluted
fraction containing the phosphopeptides and sialylated glycopeptides was dried by vacuum cen-
trifugation and subjected to an enzymatic deglycosylation in 20 mM TEAB buffer using 500 U of
PNGase F (New England Biolabs, Ipswich, MA) and 0.1 U of Sialidase A (Prozyme, Hayward, CA)
overnight at 37 °C.
Table 5
Proteins with increased N-glycan sialylation.
Accession
number
Protein name Sequence N-glycan
site
ST3GAL4
/Mock
Limma&Rank
(p-value)
Func. Grp.
O15031 Plexin-B2 ISVAGRNdeCSFQPER N844 2.89 0.0342 RS
ALSNdeISLR N127 2.08 0.0358
O60637 Tetraspanin-3 TYNdeGTNdePDAASR N127 2.96 0.0358 RS
TYNdeGTNPDAASR N127 2.98 0.0433
O75882 Attractin GICNdeSSDVR N300 2.35 0.0342 IR
P02786 Transferrin receptor protein 1 KDFEDLYTPVNdeGSIVIVR N251 1.72 0.0433 TT
P05026 Sodium/potassium-transporting ATPase sub-
unit beta-1
FKLEWLGNdeCSGLNDETYGYK N158 2.79 0.0479 TT
P06213 Insulin receptor HNdeLTITQGK N445 2.45 0.0479 RS
P06731 Carcinoembryonic antigen-related cell adhe-
sion molecule 5
TLTLFNdeVTR N204 2.67 0.0342 AM
TLTLFNVTRNdeDTASYK N208 3.11 0.0342
P06756 Integrin alpha-V ISSLQTTEKNdeDTVAGQGER N874 4.02 0.0342 AM
NdeMTISR N554 4.02 0.0342
P07602 Prosaposin TNdeSTFVQALVEHVKEECDR N215 2.59 0.0479 O
P08962 CD63 antigen CCGAANdeYTDWEK N150 1.94 0.0394 RS
P10909 Clusterin EIRHNdeSTGCLR N291 2.12 0.0342 O
P11117 Lysosomal acid phosphatase QTPEYQNdeESSR N177 3.05 0.0383 E
P12821 Angiotensin-converting enzyme IGLLDRVTNdeDTESDINYLLK N445 2.62 0.0456 P
P13473 Lysosome-associated membrane glycoprotein
2
LNdeSSTIK N275 3.09 0.0342 AM
VASVINdeINPNdeTTHSTGSCR N253 1.96 0.0358
VASVININPNdeTTHSTGSCR N257 2.06 0.0456
P13688 Carcinoembryonic antigen-related cell adhe-
sion molecule 1
NdeQSLPSSER N363 2.76 0.0479 AM
P13726 Tissue factor RNdeNTFLSLR N169 5.52 0.0342 P
NdeNTFLSLR N169 5.76 0.0358
P18564 Integrin beta-6 EVEVNdeSSK N463 3.71 0.0479 AM
P21589 5'-nucleotidase LDNdeYSTQELGK N333 1.67 0.0479 E
P26006 Integrin alpha-3 ELAVPDGYTNdeRTGAVYLCPLTAHK N86 2.68 0.0433 AM
P30825 High afﬁnity cationic amino acid transporter 1 LCLNNdeDTK N235 3.48 0.0297 TT
LCLNdeNdeDTK N234 3.01 0.0342
P35613 Basigin ALMNdeGSESR N268 2.91 0.0342 P
P42892 Endothelin-converting enzyme 1 NdeSSVEAFK N632 1.89 0.0394 P
DYYLNdeKTENEK N270 5.64 0.0479
P43007 Neutral amino acid transporter A VVTQNdeSSSGNdeVTHEK N201 2.58 0.0477 TT
P46059 Solute carrier family 15 member 1 NdeDSCPEVK N562 4.66 0.0358 TT
P48960 CD97 antigen WCPQNSSCVNdeATACR N38 1.87 0.0479 AM
P54760 Ephrin type-B receptor 4 CAQLTVNdeLTRFPETVPR N203 2.34 0.0342 RS
Q04912 Macrophage-stimulating protein receptor LPEYVVRDPQGWVAGNdeLSAR N841 3.26 0.0358 RS
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Table 5 (continued )
Accession
number
Protein name Sequence N-glycan
site
ST3GAL4
/Mock
Limma&Rank
(p-value)
Func. Grp.
Q08380 Galectin-3-binding protein DAGVVCTNdeETR N125 2.43 0.0358 AM
Q08722 Leukocyte surface antigen CD47 SDAVSHTGNdeYTCEVTELTREGETIIELK N111 6.51 0.0056 AM
Q11206 ST3GAL4 LFGNdeYSR N61 5.77 0.0088 O
Q12913 Receptor-type tyrosine-protein phosphatase
eta
HGSNdeHTSTYDK N582 3.15 0.0342 RS
VSDNdeESSSNdeYTYK N391 2.94 0.0342
VSDNESSSNdeYTYK N396 2.74 0.0383
GPNdeGTEGASR N525 2.76 0.0427
IHVAGETDSSNdeLNdeVSEPR N411 1.69 0.0479
SNdeDTAASEYK N142 2.77 0.0479
Q13641 Trophoblast glycoprotein CVNRNdeLTEVPTDLPAYVR N81 1.85 0.0429 RS
Q14108 Lysosome membrane protein 2 ANIQFGDNdeGTTISAVSNdeK N105 2.03 0.0394 T
ANdeIQFGDNdeGTTISAVSNK N99 1.78 0.0479
Q15043 Zinc transporter ZIP14 ALLNHLDVGVGRGNdeVTQHVQGHR N77 2.42 0.0479 TT
Q15758 Neutral amino acid transporter B(0) NdeITGTR N212 2.93 0.0479 TT
Q7Z7H5 Transmembrane emp24 domain-containing
protein 4
QYGSEGRFTFTSHTPGDHQICLHSNdeSTR N117 2.50 0.0479 T
Q8N271 Prominin-2 ILRNdeVSECFLAR N725 3.11 0.0433 O
Q92542 Nicastrin RPNdeQSQPLPPSSLQR N417 1.66 0.0483 P
Q92673 Sortilin-related receptor LTIVNdeSSVLDRPR N871 1.92 0.0479 T
SRNdeSTVEYTLNK N1986 1.67 0.0479
Q9BXB1 Leucine-rich repeat-containing G-protein
coupled receptor 4
TLDLSYNNIRDLPSFNdeGCHALEEISLQR N362 4.00 0.0358 RS
Q9BXS4 Transmembrane protein 59 LFSICQFVDDGIDLNdeRTK N90 4.09 0.0342 T
Q9H330 Transmembrane protein 245 ILGDKVNdeNTAVIEK N551 3.47 0.0433 O
Q9H5V8 CUB domain-containing protein 1 ASVSFLNFNdeLSNCERK N270 3.33 0.0342 AM
IGTFCSNdeGTVSR N180 2.93 0.0358
NdeVSGFSIANR N205 2.33 0.0358
Q9HD43 Receptor-type tyrosine-protein phosphatase H NdeATTAHNPVR N203 6.86 0.0342 RS
ETRNdeATTAPNPVR N381 2.93 0.0479
NdeTTNTSVTAER N434 2.72 0.0479
Q9P2B2 Prostaglandin F2 receptor negative regulator QRNdeNSWVK N525 3.60 0.0429 RS
Q9UN76 Sodium- and chloride-dependent neutral and
basic amino acid transporter B(0þ)
SPIVTHCNdeVSTVNdeK N174 2.44 0.0420 TT
Q9Y639 Neuroplastin ANdeATIEVK N229 2.59 0.0429 AM
List of signiﬁcantly increased sialylated N-glycan modiﬁed peptides in the ST3GAL4 overexpressing cells compared to mock control shown with accession number, protein name, peptide
sequence and the identiﬁed N-glycan site. The fold in increase, p-value and the protein's functional group are also presented. AM: Adhesion and migration; E: Metabolic enzyme; RS:
Receptor and signaling; T: Trafﬁcking; TT: Transmembrane transporter; P: Protease; O: Others.
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Table 6
Proteins with decreased N-glycan sialylation.
Accession number Protein name Sequence N-glycan site ST3GalIV/Mock Limma & rank
(p-value)
O14672 Disintegrin and metal-
loproteinase domain-
containing protein 10
NdeISQVLEK N439 0.57 0.0149
P07602 Proactivator
polypeptide
NdeSTKQEILAALEK N426 0.57 0.0474
List of signiﬁcantly decreased sialylated N-glycan modiﬁed peptides in the ST3GAL4 overexpressing cells compared to mock
control shownwith accession number, protein name, peptide sequence and the identiﬁed N-glycan site, fold in increase and the
p-value.
S. Mereiter et al. / Data in Brief 7 (2016) 814–833 831To separate phosphorylated peptides and formerly glycosylated peptides, the samples were sub-
jected to a second TiO2 enrichment procedure to separate phosphorylated from deglycosylated
peptides. The supernatant containing the deglycosylated peptides was saved and the beads were
washed with 50% ACN, 0.1% TFA. The washing was added to the supernatant. The deglycosylated
fraction was desalted on Oligo R3 staged tip column and dried prior to the HILIC fractionation [7]. All
fractions were dried by vacuum centrifugation prior nLC-MS/MS analysis.
7.3. Sialic acid containing glycopeptide analysis by nLC-MS/MS
Samples were resuspended in 6 mL of 0.1% TFA for analysis. Peptides were loaded on an in-house
packed Reprosil-Pur C18-AQ (2 cmx100 mm, 5 mm; Dr. Maisch GmbH, Germany) pre-column and
separated on an in-house packed Reprosil-Pur C18-AQ (17 cmx75 mm, 3 mm; Dr. Maisch GmbH,
Germany) column using an Easy-nLC II system (Thermo Scientiﬁc, Bremen, Germany) and eluted at a
ﬂow of 250 nL/min. Mobile phase was 95% acetonitrile (B) and water (A) both containing 0.1% formic
acid. Depending on the samples, gradient was from 1% to 30% solvent B in 80 or 110 min, 30–50% B in
10 min, 50–100% B in 5 min and 8 min at 100% B. Mass spectrometric analyses were performed in an
Orbitrap Fusion Tribrid system (Thermo Scientiﬁc, Bremen, Germany). MS scans (400–1200 m/z) were
acquired in the orbitrap at a resolution of 120000 at 200 m/z for a AGC target of 5105 ions and a
maximum injection time of 60 ms. Data-dependent HCD MS/MS analysis at top speed of the most
intense ions were performed at a resolution of 30000 at 200 m/z for a AGC target of 5104 and a
maximum injection time of 150 ms using the quadrupole to isolate the ions and an isolation window
of 1.2 m/z, a NCE of 38% and a dynamic exclusion of 20 s.
The raw data were processed and quantiﬁed by Proteome Discoverer (version 1.4.1.14, Thermo
Scientiﬁc) against SwissProt and Uniprot human reference databases by using Mascot (v2.3.02, Matrix
Science Ltd, London, UK) and Sequest HT, respectively. Database searches were performed using the
following parameters: precursor mass tolerance of 10 ppm, product ion mass tolerance of 0.02 Da,
1 missed cleavages for trypsin, carbamidomethylation of Cys and iTRAQ labeling on protein
N-terminal and Lys as ﬁxed modiﬁcations, and phosphorylation on S/T/Y and deamidation of Asn as
dynamic modiﬁcations. The iTRAQ datasets were quantiﬁed using the centroid peak intensity with
the “reporter ions quantiﬁer” node. Only peptides with up to a q-value of 0.01 (Percolator), Mascot
and Sequest HT rank 1, Sequest HT ΔCn of 0.1, cut-off value of Mascot score Z 18 and a cut-off value
of XCorr score for charge states of þ1, þ2, þ3, and þ4 higher than 1.5, 2, 2.25 and 2.5, respectively,
were considered for further analysis.
7.4. Data normalization and signiﬁcance analysis
Three biological replicates were analyzed and submitted to the statistical analysis. The log2 values
of the measured intensities were normalized by the median. Modiﬁed peptides were merged with the
R Rollup function (http://www.omics.pnl.gov) allowing for one-hit-wonders and using the mean of
the normalized intensities for each peptide. Quantiﬁcation of proteins was obtained by merging the
S. Mereiter et al. / Data in Brief 7 (2016) 814–833832un-modiﬁed peptides with the R Rollup function considering at least 2 unique peptides not allowing
for one-hit-wonders and using the mean of the intensities. Then the mean over the experimental
conditions for each peptide in each replicate was subtracted in order to merge data from different
iTRAQ runs. Formerly sialylated glycopeptides containing the consensus motif for N-linked glycosy-
lation (NXS/T/C; where X # P) were normalized based on the protein expression in each of the
replicates. Signiﬁcant up/down-regulations between experimental conditions were calculated
allowing a false discovery rate of 0.05. Therefore, we applied combined limma and rank product tests
[9], subsequently corrected for multiple testing according to Storey.
Since spontaneous deamidation is frequently observed for asparagine residues, especially when
the C-terminal amino acid is glycine (NG), the sites with NGS/T/C are considered as only potential
glycosylation. However, in order to reduce the contribution from spontaneous deamidation in the
ﬁnal list, we sort ﬁrst for the N-linked consensus site (NXS/T/C) and then we ﬁlter for proteins that
are membrane-associated in order to exclude intracellular proteins that are not N-linked glycosy-
lated (Tables 5 and 6).Acknowledgments
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